ABSTRACT Ventilation-perfusion (VA/Q) relationships and gas exchange were studied by the multiple inert gas technique in 19 patients admitted to hospital with acute severe asthma (FEV, 41 % predicted) before and during the administration of intravenous salbutamol, inhaled salbutamol, or 100% oxygen. Eight patients received a continuous intravenous infusion of salbutamol (4 jig/min, total dose 360 ,ug) and were studied before treatment, after 60 and 90 minutes of treatment, and one hour after treatment had been discontinued. Six patients had measurements before and 15 minutes after inhaling 300 jg salbutamol from a metered dose inhaler on two occasions (total dose 600 jug) and one hour after the last dose. Measurements were also made in five patients before and while they breathed 100% oxygen for 20 minutes. At baseline (fractional inspired oxygen (Fio2) 21%) all patients showed a broad unimodal (n = 10) or bimodal (n = 9) distribution of blood flow with respect to VA/Q. A mean of 10-5% of the blood flow was associated with low VA/) units without any appreciable shunt. One of the best descriptors of VA/) inequality, the second moment of the perfusion distribution on a log scale (log SD Q), was moderately high with a mean of 1 18 (SEM 0 08) (normal < 0-6). Measures of VA/( inequality correlated poorly with spirometric findings. After salbutamol the increase in airflow rates was similar regardless of the route of administration. Intravenous salbutamol, however, caused a significant increase in heart rate, cardiac output, and oxygen consumption (Vo2); in addition, both perfusion to low VA/4 areas and log SD 0 increased significantly. Inhaled salbutamol caused only minor changes in heart rate, cardiac output, Vo2, and VA/Q inequality. Arterial oxygen tension (Pao2) remained unchanged during salbutamol administration, irrespecive of the route of administration. During 100% oxygen breathing there was a significant increase in log SD 0 (from 1 11 to 1 44). It is concluded that patients with acute severe asthma show considerable VA/Q inequality with a high level of pulmonary vascular reactivity. Despite similar bronchodilator effects from inhaled and intravenous salbutamol, VA/0 relationships worsened only during intravenous infusion. Pao2 remained unchanged, however, because the change in VA/Q relationships was associated with an increase in metabolic rate and cardiac output.
Introduction nised ventilation-perfusion (VA/Q) mismatching as the fundamental mechanism underlying abnormal gas Gas exchange abnormalities, particularly hypox-exchange in asthma.2"5 More direct evidence has come aemia, are well known accompaniments of exacerba-from quantitative measurements of VA/4 relationtions of asthma, the degree of hypoxaemia showing a ships since the introduction of the multiple inert gas poor correlation with indices of severity of airflow elimination technique.f" Bronchodilators, though obstruction.' Several studies have indirectly recog-improving airflow rates in asthma, have been found to alter pulmonary gas exchange.'2 Thus the administra-Ventilation-perfusion mismatching in acute severe asthma: effects ofsalbutamol and 100% oxygen results have been reported on the effects of beta agonists. Wagner et al6 observed a transient deterioration in Pao2 and VA/0 relationships in symptomless adults with asthma after giving inhaled isoprenaline. In a subsequent study by the same authors,'4 inhaled metaproterenol administered after antigen challenge caused a rapid restoration of VA/0 distribution to normal in all but one patient. Young et al' also observed an improvement in both Pao2 and VA/4 relationships after salbutamol in patients with exercise induced asthma. A similar degree of improvement has been observed in children'5 and in experimental canine "asthma." '6 '7 The purpose of the present study was, firstly, to evaluate the effects on VA/0 distribution of a beta2 selective agonist, salbutamol, administered by two different routes in patients with acute severe asthma, and to examine the relation of any change to spirometric, haemodynamic, and gas exchange data;
and, secondly, to assess whether hypoxic pulmonary vasoconstriction is present by determining the effects of 100% oxygen breathing on VA/4 mismatching.
Methods

SUBJECTS
Nineteen non-smoking subjects with asthma (17 women and two men) were included in the study. FVC-forced vital capacity; FEV,-forced expiratory volume in one second; PEF-peak expiratory flow; VE-minute ventilation; HR-heart rate;
OT-Cardiac output; MSAP-mean systemic arterial pressure; Pao2-arterial oxygen tension; Paco2-arterial carbon dioxide tension; A-aPo2-alveolararterial oxygen gradient; Vo2-oxygen consumption; Vco2-carbon dioxide production.
Ventilation-perfusion mismatching in acute severe asthma: effects ofsalbutamol and 100% oxygen below the therapeutic range (mean (SD) 1 9 (0-5) (range 0-49) mg/i). Mean heart rate and mean systemic arterial pressure were within the normal range (table 1) . CT was slightly increased (6 08 (0 27) 1/min, cardiac index 3 77 (0-18)1 min-'/m2). Mean VE was 8-5 (0 4) 1/min and Vo2 258 (16) ml/min. Mean Pao2 was low at 70 7 (2 9) mm Hg* and less than 75 mm Hg in all but three patients. Mean Paco2 was slightly reduced at 35-1 (0 9) mm Hg and was above 40 mm Hg in only one patient. The mean alveolararterial Po2 difference (A-aPo2) was increased at 35-6 (3) mm Hg. The mean physiological dead space (Bohr) was also slightly increased at 37T5% (2%).
The VA/Q distributions were characterised by either a broadly unimodal (n = 10) or a bimodal (n = 9) blood flow distribution with a substantial amount of perfusion associated with low VA/( units (11% (3%) with VA/( < 0-1, excluding shunt). There were large individual differences in the amount of perfusion of IOW VA/0 areas (range 0-38%). High VA/4 areas (VA/ Q > 10, excluding inert dead space-that is, areas with VA/0 > 100) were not seen. Indices of dispersion of blood flow (log SD Q) and ventilation (log SDV) were increased (118 (0-08) and 0-77 (0-03) respectively, normal range 0.3-0.6).' These variables, which represent the second moment of pulmonary blood flow and alveolar ventilation distribution respectively, are measured on a natural log scale. ug salbutamol and by 56% after 600 pg: p < 0 01); one hour after the last dose ofsalbutamol airflow remained increased (p < 0-0 1). These changes were not significantly different from those observed during the salbutamol infusion. Similar changes were evident with PEF (p < 0 01). In contrast to the intravenous study, there were no significant changes in heart rate, cardiac output, or mean systemic arterial pressures.
Blood gas tensions and Vo2 Pao2, Paco2, A-aPO2, and Vo2 values remained unchanged throughout the study. VA/Q distribution VA/( inequality remained unchanged throughout the study as assessed by log SD 4. Although the existence and magnitude of such modes can generally be well defined, there are occasions when the inert gas elimination technique is limited to distinguishing unimodal from bimodal distributions unless linear programming is used. studying subjects with mild to moderate asthma under resting conditions, found unimodal blood flow distributions only. The different patterns of VA/Q inequality in the two studies may be due to selection of patients, the different clinical conditions in which they were studied, the degree of airway obstruction, and previous drug treatment with bronchodilators.
Recently Wagner et al"' have shown that VA/0 mismatch is present in most asthmatic patients with and the dispersion index of blood flow, log SD (). despite a return to normal in maximal expiratory flow rates after inhalation of isoproterenol. In our study intravenous salbutamol caused further VA/0 mis-Ballester, Reyes, Roca, Guitart, Wagner, Rodriguez-Roisin matching, a substantial increase in cardiac output, and an increase in oxygen consumption, the net effect of which was that Pao, was unaltered. In contrast, with inhaled salbutamol VA/4 distribution was unchanged, and there were no changes in cardiac output, oxygen consumption, or Pao,. The differences in the effects on VA/( distributions of salbutamol when administered by the two different routes can be explained by the prominent cardiac and metabolic effects that occur with the higher plasma concentrations of salbutamol achieved with intravenous administration. There are insufficient data in our study to determine whether the increase in log SD 2 is due to an increase in cardiac output or is an additional vasodilator effect. In conclusion, both forms of administration of salbutamol improved airflow rates, and Pao2 and log SD ( were similar to initial values after either form of administration after discontinuation of intravenous treatment. These results are therefore consistent with the belief that VA/0 mismatching in asthma is related to abnormal functioning of peripheral airways while airflow rates are essentially reflecting more central airways obstruction-hence the dissociation between spirometric measurements and gas exchange." During the intravenous administration of salbutamol the remarkable finding was the considerable worsening of VA/4 inequality, contrasting with the lack of VA/0 changes with inhaled salbutamol.
CLINICAL IMPLICATIONS
From this study some clinical conclusions may be drawn. Firstly, the two routes of salbutamol administration have the same beneficial effect in relieving bronchial obstruction. Secondly, inhalation of salbutamol seems to be the better therapeutic approach because of the lack of deleterious effects on VA/Q) relationships. Although neither form of administration led to any substantial change in Pao2, when cardiac disease blunts the compensating rise in cardiac output intravenous salbutamol could probably aggravate pre-existing hypoxaemia, whereas with the inhaled route this would not be likely to occur. In addition, the lack of increase in oxygen consumption with inhaled salbutamol (which would allow No2 to increase, other things being equal) would tend also to offset any further decrease in Pao,.
RESPONSE TO 100% OXYGEN Wagner et al6 found no change in VA/4) relationships in four symptom free patients with asthma when they were breathing 100% oxygen. In contrast, a group of patients with symptoms studied by Corte and Young9 showed a deterioration in VA/4 relationships when breathing 100% oxygen and in a few patients a small shunt appeared. In the present study, it seems clear that hypoxic pulmonary vasoconstriction had a major role in determining ventilation-perfusion matching, as VA/0 inequality worsened considerably after administration of 100% oxygen. Patients with symptoms probably have more hypoxic vasoconstriction than symptom free patients. We have shown similar results in patients with severe asthma requiring mechanical ventilation33 and in those with chronic severe asthma.34
